Trial Profile
Phase II trial of cenderitide in hospitalised patients with acute decompensated heart failure.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 05 Apr 2012
Price :
$35
*
At a glance
- Drugs Cenderitide (Primary)
- Indications Decompensated heart failure
- Focus Therapeutic Use
- Sponsors Nile Therapeutics
- 05 Apr 2012 Planned initiation date changed from 1 Jan 2012 to 1 Jun 2012.
- 02 Mar 2011 New trial record